Ethylene

Ethylene

SCHEMBL688287

C=C.CC(C)(OC(=O)O)OC(=O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
DGAT1 O75907 1/20 0.35
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4456119 0.94 TSHR (0.39) ALDH1A1TSHRDGAT1
SCHEMBL9862055 0.82 TSHR (0.35) ALDH1A1TSHRLMNA
Ethylene SCHEMBL18227133 0.81 DGAT1 (0.46) ALDH1A1TSHRDGAT1LMNA
SCHEMBL2311514 0.81 ALDH1A1 (0.35) ALDH1A1TSHR
SCHEMBL9860832 0.80 ALDH1A1 (0.42) ALDH1A1TSHR
SCHEMBL14905772 0.79
Ethylene SCHEMBL21817643 0.77 DGAT1 (0.37) ALDH1A1TSHRDGAT1
SCHEMBL9420099 0.77 DGAT1 (0.32) ALDH1A1TSHRDGAT1
SCHEMBL23125480 0.76
SCHEMBL44413 0.75 TSHR (0.42) ALDH1A1TSHRDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1180809-B1 Non-aqueous electrolyte secondary cell SONY CORP (JP) 2012-02-29 EP claimed
US-6399255-B2 Rechargeable lithium electrochemical cell usable at low temperature ALCATEL (FR) 2002-06-04 US claimed
US-20010019800-A1 A RECHARGEABLE LITHIUM ELECTROCHEMICAL CELL USABLE AT LOW TEMPERATURE SAFT FINANCE S.AR.L. (LU) 2001-09-06 US claimed
US-12537187-B2 Electrode and lithium ion secondary battery ADEKA CORPORATION (JP) 2026-01-27 US disclosed
WO-2023233724-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY オルガノ株式会社 2023-12-07 WO disclosed
US-20230238511-A1 ELECTRODE AND LITHIUM ION SECONDARY BATTERY ADEKA CORPORATION (JP) 2023-07-27 US disclosed
WO-2023085245-A1 COMPOSITION, ELECTRODE, BATTERY, AND ELECTRODE ACTIVE MATERIAL 株式会社ADEKA 2023-05-19 WO disclosed
EP-4167313-A1 ELECTRODE AND LITHIUM ION SECONDARY BATTERY ADEKA CORPORATION (JP) 2023-04-19 EP disclosed
CN-115702509-A Electrode and lithium ion secondary battery 株式会社ADEKA 2023-02-14 CN disclosed
EP-3352281-B1 NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY ADEKA CORP (JP) 2021-08-11 EP disclosed
US-10734684-B2 Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery ADEKA CORPORATION (JP) 2020-08-04 US disclosed
US-20130177822-A1 NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY ADEKA CORPORATION (JP) 2013-07-11 US disclosed
EP-2613395-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Adeka Corporation (JP) 2013-07-10 EP disclosed
US-20130149603-A1 NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY ADEKA CORPORATION (JP) 2013-06-13 US disclosed
EP-1180809-B1 Non-aqueous electrolyte secondary cell SONY CORP (JP) 2012-02-29 EP disclosed
CN-1220292-C Nonaqueous electrolyte secondary battery SONY CORP (JP) 2005-09-21 CN disclosed
US-6677080-B2 IMPROVED ANTI-OVER DISCHARGE CHARACTERISTIC USING LITHIUM-NICKEL COMPOSITE OXIDE AS CATHODE ACTIVE MATERIAL AND GRAPHITE AS ANODE MATERIAL SONY CORPORATION (JP) 2004-01-13 US disclosed
US-20020076612-A1 Non-aqueous electrolyte secondary cell MURATA MANUFACTURING CO., LTD. (JP) 2002-06-20 US disclosed
CN-1341975-A Nonaqueous electrolyte secondary battery SONY CORP (JP) 2002-03-27 CN disclosed
EP-1180809-A2 Non-aqueous electrolyte secondary cell SONY CORPORATION (JP) 2002-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12537187-B2 Electrode and lithium ion secondary battery HCN4, TTN, PARN ALDH1A1 2925/4885TSHR 1621/4885DGAT1 4553/4885
US-10734684-B2 Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery KCNN1, KCNN2, SLC9A1 ALDH1A1 1638/4885TSHR 3742/4885DGAT1 2226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.